NRAS and colorectal carcinoma: Yeager et al. performed RAS mutation analysis in 918 CRC patients, and showed that patients with NRAS and/or KRAS mutations had statistically significant higher incidence of BM (6.1 vs. 1.9 % in wild type patients), even after controlling for age, tumor location and previous diagnosis of lung metastasis [26].